Sign in

You're signed outSign in or to get full access.

John Daly

Director at CareCloud
Board

About John N. Daly

Independent director since December 2013; age 87 as of December 31, 2024. Daly is Chairman of the Compensation Committee and a member of the Audit Committee, bringing five decades of capital markets and asset management experience. He earned a BA from Yale University and completed the Harvard Business School Advanced Management Program in 1979 .

Past Roles

OrganizationRoleTenureCommittees/Impact
IMMS, LLCPresidentMay 2007–presentThird‑party marketer of investment managers; extensive distribution/network expertise
E.F. Hutton & Co.Senior leadership (ran Syndicate, Commodities, Asset Management divisions)1960–1983Led core revenue-generating units; capital markets and product management experience
Salomon Brothers (NY/London)Head, Private Client Division & International Equity Capital MarketsNot disclosedGlobal equity capital markets leadership; international governance exposure
Prudential InvestmentsSenior Managed Accounts Specialist2002–2005Managed accounts expertise; product governance

External Roles

  • No current public company directorships disclosed for Daly in the proxy statements .
  • Private company role: President, IMMS, LLC (investment management marketing) .

Board Governance

  • Committee assignments: Chairman, Compensation Committee; Member, Audit Committee (independent) .
  • Independence: Board determined Daly is independent under Nasdaq rules .
  • Attendance: In 2024 the Board held 5 meetings, committees met (Audit 5; Compensation 4; Nominating 4; Cybersecurity 4); each director attended at least 75% of Board and applicable committee meetings .
  • Annual meeting participation: 3 directors attended the 2024 annual meeting; 2 directors attended in 2023 (names not specified) .
  • Director compensation policy: Non‑employee directors receive a monthly retainer plus RSUs; no meeting fees; Audit Chair receives an additional retainer .
  • Compensation Committee interlocks: Compensation Committee comprised of Daly and Munter; neither was an officer/employee or former officer of the Company during 2024 and 2023 .

Fixed Compensation

MetricFY 2023FY 2024
Cash Retainer ($)$48,000 $48,000
Stock Awards ($)$51,913 $40,700
Total ($)$99,913 $88,700

Performance Compensation

MetricQ3 2023 GrantQ3 2024 Grant
RSUs Awarded (shares)30,000 each to outside directors 30,000 each to outside directors
Vesting Start DateFebruary 2024 February 2025
Vesting Cadence25% increments over 2 years 25% increments over 2 years
Outstanding RSUs at Year‑End (Daly)27,500 (as of 12/31/2023) 45,000 (as of 12/31/2024)

Awards to non‑employee directors are automatic under the director compensation policy; the Committee may not make discretionary grants to directors under the Equity Plan . Change‑in‑control terms provide one‑year vesting acceleration unless otherwise provided in award documents .

Other Directorships & Interlocks

CategoryDisclosed Detail
Current public company boardsNone disclosed for Daly
Prior public company boardsNot disclosed for Daly
Private/non‑profit boardsIMMS, LLC (President)
Committee interlocksCompensation Committee (Daly, Munter); no officer/employee participation

Expertise & Qualifications

  • Capital markets and asset management: Senior roles at E.F. Hutton (Syndicate, Commodities, Asset Management), Salomon Brothers (International ECM), Prudential Investments (managed accounts) .
  • Distribution/third‑party marketing for investment managers (President, IMMS, LLC) .
  • Education: BA Yale; Harvard Business School AMP (1979) .

Equity Ownership

MetricApr 18, 2024 (Record Date)Mar 31, 2025 (Record Date)
Common Stock Beneficially Owned (shares)64,250 76,750
Percent of Class0.4% (16,118,492 shares outstanding) 0.2% (42,321,129 shares outstanding)
Series B Preferred Beneficially Owned (shares)
Percent of Class (Series B)

Hedging and pledging policy: Directors are prohibited from hedging and margin pledging; any pledge requires pre‑approval and demonstration of repayment capacity without resort to pledged securities .

Governance Assessment

  • Board effectiveness: Daly chairs Compensation and sits on Audit, aligning expertise with oversight of pay structure and financial controls; committee responsibilities include selecting independent compensation consultants, plan oversight, and annual self‑evaluations . Audit Committee duties include oversight of financial reporting, internal controls, auditor independence, and cybersecurity subcommittee .
  • Independence and engagement: Daly is an independent director; attendance met at least 75% threshold in 2024; committee workloads were regular and robust (Audit 5; Compensation 4) .
  • Ownership alignment: Daly holds common stock and receives annual RSUs with multi‑year vesting; no Series B holdings; hedging/pledging restrictions support alignment with shareholders .
  • Pay structure: Director pay emphasizes fixed cash retainers and equity grants without meeting fees; Audit Chair alone receives extra retainer, reinforcing role‑based pay rather than attendance‑based fees .
  • Shareholder signals: Say‑on‑pay support remained strong (2024: 7.41M For vs 0.62M Against vs 0.17M Abstain; 2025: 10.99M For vs 2.75M Against vs 0.26M Abstain), indicating generally favorable investor alignment with compensation governance .
  • Conflicts: No related‑party transactions involving Daly disclosed; company‑level related‑party exposures centered on Executive Chairman leases, family physician customer, and a board member consulting arrangement, all under Audit Committee policy review. Daly’s role on Audit/Comp helps oversee such policies .

Say‑On‑Pay Voting Outcomes

Metric20242025
For7,408,190 10,991,919
Against623,892 2,754,093
Abstain166,268 255,951

Voting quorum context: 16,118,492 common shares outstanding (2024); 42,321,129 common shares outstanding (2025) .